Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism
- Registration Number
- NCT00770016
- Lead Sponsor
- University of Aarhus
- Brief Summary
The aim of this study is to further characterize the treatment related changes in insulin sensitivity, substrate metabolism and intra hepatic- and intramyocellular lipid content in patients with hypothyroidism
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- written informed consent
- must be of legal age and competent
- Age > 18 years
- presently diagnosed with hypothyroidism
Exclusion Criteria
- alcohol consumption >21 units per week
- Malignant disease
- pregnancy
- magnetic implants or material in the body
- BMI > 30
- Heart disease (NYHA >2)
- Uncontrolled hypertension
- Manifest diabetes mellitus
- Changes in medication, with any influence on glucose metabolism, 2 months prior to and until the end of the trial.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1 Levothyroxin the aim of the present study is to characterize the treatment related changes in insulin sensitivity, substrate metabolism and intrahepatic - intramyocellular lipids in 12 adult patients, recently diagnosed with hypothyroidism
- Primary Outcome Measures
Name Time Method intracellular lipid content in liver and muscle before and after 3 months treatment with growth hormone intraabdominal lipid content before and after treatment insulin sensitivity before and after treatment substrate metabolism before and after treatment intracellular signaling in the basal state and during insulin stimulation before and after treatment
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link hypothyroidism to altered insulin sensitivity and lipid metabolism?
How does levothyroxin treatment compare to other thyroid hormone replacement therapies in improving insulin sensitivity?
Which biomarkers correlate with changes in intrahepatic and intramyocellular lipid content during hypothyroidism treatment?
What are the potential adverse metabolic effects of levothyroxin therapy in hypothyroid patients?
How do thyroid hormone receptor agonists compare to levothyroxin in modulating substrate metabolism in hypothyroidism?
Trial Locations
- Locations (1)
Medical department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus Sygehus,
🇩🇰Aarhus, Denmark
Medical department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus Sygehus,🇩🇰Aarhus, Denmark